Interposition graft from aortobifemoral graft to common     femoral artery.
[**2104-5-27**]: Reexploration of right groin thrombectomy of right aortobifemoral graft limb and interposition common femoral artery graft.
Angioplasty and stenting with a 13 mm Viabahn self-expanding stent graft of the stenosis in the right aortobifemoral graft limb.
Balloon thrombectomy of right femoral-popliteal graft and popliteal artery.
Balloon thrombectomy of the tibial peroneal trunk and peroneal artery.
Exploration and balloon thrombectomy of the distal posterior tibial artery.
Four-compartment fasciotomy and arteriography of the aortobifemoral graft and right lower extremity.
Portex 8.0 tracheostomy tube placement.
A 20-French Ponsky tube percutaneous endoscopic     gastrotomy placement.
History of Present Illness: Pt is a 67M with a h/o PVD s/p s/p Aorto-Bifiem bypass, bilateral fem-[**Doctor Last Name **] bypass who was transfered to the [**Hospital1 18**] cardiology service.
He was cardioverted, and post cardioversion he was noted to have a new RBBB and ST elevations.
He has been on a heparin gtt, but no recent interventions have been performed on the leg.
Peripheral Vascular Disease, s/p aorto [**Hospital1 **]-fem bypass, s/p bilateral fem-[**Doctor Last Name **] bypass (all @ [**Hospital6 **]- [**Doctor First Name **] [**Doctor Last Name 27785**]).
Family History: Non contrib  Pertinent Results: [**2104-6-12**] 01:27AM BLOOD WBC-12.1* RBC-2.80* Hgb-8.1* Hct-25.2* MCV-90 MCH-28.9 MCHC-32.1 RDW-13.7 Plt Ct-330 [**2104-5-26**] 06:11PM BLOOD WBC-10.8 RBC-3.99* Hgb-12.0* Hct-34.2* MCV-86 MCH-30.2 MCHC-35.3* RDW-13.8 Plt Ct-167 [**2104-6-12**] 03:25AM BLOOD PT-13.3 PTT-66.5* INR(PT)-1.1 [**2104-6-12**] 03:25AM BLOOD Glucose-96 UreaN-44* Creat-1.4* Na-140 K-4.5 Cl-104 HCO3-27 AnGap-14 [**2104-6-10**] 03:57AM BLOOD ALT-89* AST-83* CK(CPK)-3012* AlkPhos-222* TotBili-1.0 [**2104-5-26**] 06:11PM BLOOD CK(CPK)-[**Numeric Identifier 78848**]* [**2104-6-6**] 03:42AM BLOOD Lipase-43 [**2104-6-4**] 11:14PM BLOOD CK-MB-10 MB Indx-0.2 cTropnT-1.83* [**2104-5-26**] 06:11PM BLOOD CK-MB-269* MB Indx-1.4 cTropnT-0.66* [**2104-6-12**] 03:25AM BLOOD Calcium-8.3* Phos-4.6* Mg-2.9* [**2104-6-12**] 09:07AM BLOOD Type-MIX pO2-60* pCO2-43 pH-7.40 calTCO2-28 Base XS-0 Comment-GREEN TOP [**2104-6-4**] 12:33PM BLOOD O2 Sat-89 [**2104-6-12**] 08:06AM BLOOD freeCa-1.09*  [**5-26**]: CXR - Opacification in the left lower lung accompanied by marked leftward mediastinal shift reflects lower lobe collapse.
Right jugular line ends in the SVC.
ET tube tip at the thoracic inlet between 4 and 5 cm from the carina is acceptable with the chin elevated.
Nasogastric tube is folded in the stomach.
The previous CFA aneurysmal segment is nos s/p surgical repair and there was a noted "kink" in the mid-segment of the repair.
There is flow to the fem-popliteal bypass on the right with occlusion of the native SFA and PFA noted.
She had a cardiac catheterization, and subsequently went to the operating room with the vascular service for and exploration of the right groin,  thrombectomy of right limb aortobifemoral graft, resection of right femoral artery pseudoaneurysm, interposition graft from aortobifemoral graft to common,    femoral artery, Thrombectomy left limb aortobifemoral graft, left above-knee amputation.
The patient remained intubated and sedated and returned to the CVICU for further care.
Neuro: The patient received a fentanyl drip initally with good effect and adequate pain control.
Post operatively, the patient was intermittently confused and agitated; Haldol and other sedatives were given.
Sedation was weaned when appropriate.
CV:  On [**5-26**], the patient underwent a cardiac catheterization with successful revascularization and stent placement.
Presedex was stopped at that time.
Lopressor, and other cardiac medications were adjusted when appropriate to maintain stable vital signs.
The patient's metoprolol was dosed accordingly, and on admission, the patient was receiving metoprolol 125 mg TID.
Pulmonary:  Post operatively, the patient remained intubated and sedated.
By [**6-5**], thoracic surgery was consulted for trach/peg placement; trach sutures were to remain in place until [**6-14**].
Tube feeds were started on POD [**3-11**] via DObhoff; nutrition was consulted for tube feed recommendations.
By [**6-5**], thoracic surgery was consulted for trach/peg placement (the heparin drip was held for that procedure).
The patient's intake and output were closely monitored, and IVF were adjusted when necessary.
The patient was started on ciprofloxacin on POD [**2-10**]; a urinary tract infection was suspected from her urinalysis results.
Vancomycin was initiated on [**6-5**], and cipro was stopped.
Ceftriaxone was started on [**6-6**], and vanc was stopped.
Hematology:  The patient was maintained on aspirin, heparin drip for anticoagulation.
On POD [**1-9**], the patient was transfused 2 units of packed red blood cells.
Prophylaxis:  The patient received a heparin drip and aspirin during this stay.
The patient was transitioned to aspirin, plavix and coumadin.
Other:  Plastic surgery was consulted for evaluation of gluteal wounds, who recommended enzymatic debridement with further mechanical debridement possible when stable.
Wound care was also consulted for evaluation and treatment.
The patient was to continue with Accuzyme to the wound, and no futher mechanical debridement was necessary.
The patient was tolerating a tube feeds.
Medications on Admission: Aspirin 81mg Atenolol 100mg po qday Multivitamin  Discharge Medications: 1.
Chlorhexidine Gluconate 0.12 % Mouthwash Sig: One (1) ML Mucous membrane [**Hospital1 **] (2 times a day).
Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Insulin Lispro 100 unit/mL Solution Sig: variable Subcutaneous ASDIR (AS DIRECTED): per sliding scale.
Albuterol 90 mcg/Actuation Aerosol Sig: Six (6) Puff Inhalation Q4H (every 4 hours) as needed.
Metoclopramide 10 mg Tablet Sig: One (1) Tablet PO QID (4 times a day).
Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Zinc Sulfate 220 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
Papain-Urea 830,000-10 unit/g-% Spray, Non-Aerosol Sig: One (1) Appl Topical DAILY (Daily).
Metoprolol Tartrate 50 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day).
Fentanyl 50 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr Transdermal Q72H (every 72 hours).
Warfarin 1 mg Tablet Sig: variable Tablet PO DAILY (Daily): goal INR [**2-10**].
Bisacodyl 5 mg Tablet, Delayed Release (E.C.)
Senna 8.6 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Oxycodone-Acetaminophen 5-325 mg/5 mL Solution Sig: Five (5) ML PO Q6H (every 6 hours) as needed.
Metolazone 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Captopril 12.5 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Warfarin 5 mg Tablet Sig: One (1) Tablet PO ONCE (Once) for 1 doses.
Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO QHS (once a day (at bedtime)).
Furosemide 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
CeftriaXONE 1 gm IV Q24H 24.
Heparin (Porcine) in D5W 100 unit/mL Parenteral Solution Sig: 1600 (1600) u/ml Intravenous ASDIR (AS DIRECTED): goal PTT 60-80, d/c hep gtt when INR >2.
Heparin Flush (10 units/ml) 2 mL IV PRN line flush PICC, heparin dependent: Flush with 10mL Normal Saline followed by Heparin as above daily and PRN per lumen.
STEMI s/p cardiac catherization @ outside hospital 2.
Thrombosed aortobifemoral graft 3.
VAP   Discharge Condition: Stable  Discharge Instructions: 1.. Continue coumadin & heparin drip until INR >2, then d/c heparin drip 2.Staples may be removed on [**2104-6-18**]  Followup Instructions: Please call Dr.[**Name (NI) 5695**] office at ([**Telephone/Fax (1) 18181**] to arrange for a follow up appointment
